Edto, Fahmia .
HRN: 20-46-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/21/2025
CEFTRIAXONE 1G (VIAL)
02/21/2025
02/28/2025
IV
700mg
Q 24
T/C AGE; R/O Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes